Medicine & Life Sciences
Type 2 Diabetes Mellitus
100%
Metformin
76%
Glucose
73%
Insulin
67%
Hypoglycemic Agents
48%
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
30%
Insulin Resistance
28%
Glucagon-Like Peptide 1
22%
Hyperglycemia
21%
Obesity
18%
Insulin Secretion
18%
Therapeutics
16%
Fatty Acids
15%
Hypoglycemia
15%
Palmitates
15%
Peptides
15%
2,4-thiazolidinedione
13%
Dipeptidyl-Peptidase IV Inhibitors
13%
Rosiglitazone
13%
Dipeptidyl Peptidase 4
11%
Glucagon-Like Peptide-1 Receptor
11%
Weight Loss
11%
Thiazolidinediones
11%
Gastric Inhibitory Polypeptide
11%
Pharmaceutical Preparations
10%
Peroxisome Proliferator-Activated Receptors
10%
Blood Glucose
10%
Placebos
10%
Safety
10%
sibutramine
10%
Incretins
10%
Sodium-Glucose Transporter 2 Inhibitors
9%
Sodium-Glucose Transport Proteins
9%
BTS 67582
9%
Glucagon
9%
Islets of Langerhans Transplantation
9%
Biguanides
8%
lixisenatide
8%
PPAR gamma
8%
Liver
8%
Pioglitazone
8%
LY3298176
7%
glucagon-like peptide 1 (7-36)amide
7%
Leptin
7%
Meals
7%
Symporters
7%
Diabetes Complications
7%
Hormones
7%
Insulin-Secreting Cells
7%
Obese Mice
7%
Chemistry
Insulin Derivative
37%
Metformin
20%
Antidiabetic Agent
20%
Insulinotropic
19%
Glucose
18%
Polypeptide
9%
Glucagon-Like Peptide 1
9%
Metabolic
8%
Saturated Fatty Acid
7%
Leptin
7%
Fatty Acid
7%
Glycemic
5%
Plasma
5%
Resistance
5%
Peptide
5%
Ceramide
5%
Hormone
5%